These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1999 related articles for article (PubMed ID: 24412617)

  • 1. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.
    Singh N; Gurav A; Sivaprakasam S; Brady E; Padia R; Shi H; Thangaraju M; Prasad PD; Manicassamy S; Munn DH; Lee JR; Offermanns S; Ganapathy V
    Immunity; 2014 Jan; 40(1):128-39. PubMed ID: 24412617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR109a: the missing link between microbiome and good health?
    Jobin C
    Immunity; 2014 Jan; 40(1):8-10. PubMed ID: 24439263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon.
    Thangaraju M; Cresci GA; Liu K; Ananth S; Gnanaprakasam JP; Browning DD; Mellinger JD; Smith SB; Digby GJ; Lambert NA; Prasad PD; Ganapathy V
    Cancer Res; 2009 Apr; 69(7):2826-32. PubMed ID: 19276343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation.
    Bhatt B; Zeng P; Zhu H; Sivaprakasam S; Li S; Xiao H; Dong L; Shiao P; Kolhe R; Patel N; Li H; Levy-Bercowski D; Ganapathy V; Singh N
    J Immunol; 2018 Apr; 200(8):2905-2914. PubMed ID: 29514953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal Eating Patterns Cause Circadian Disruption and Promote Alcohol-Associated Colon Carcinogenesis.
    Bishehsari F; Engen PA; Voigt RM; Swanson G; Shaikh M; Wilber S; Naqib A; Green SJ; Shetuni B; Forsyth CB; Saadalla A; Osman A; Hamaker BR; Keshavarzian A; Khazaie K
    Cell Mol Gastroenterol Hepatol; 2020; 9(2):219-237. PubMed ID: 31689559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential.
    Gaidarov I; Chen X; Anthony T; Maciejewski-Lenoir D; Liaw C; Unett DJ
    Cell Signal; 2013 Oct; 25(10):2003-16. PubMed ID: 23770183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8.
    Cresci GA; Thangaraju M; Mellinger JD; Liu K; Ganapathy V
    J Gastrointest Surg; 2010 Mar; 14(3):449-61. PubMed ID: 20033346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome.
    Macia L; Tan J; Vieira AT; Leach K; Stanley D; Luong S; Maruya M; Ian McKenzie C; Hijikata A; Wong C; Binge L; Thorburn AN; Chevalier N; Ang C; Marino E; Robert R; Offermanns S; Teixeira MM; Moore RJ; Flavell RA; Fagarasan S; Mackay CR
    Nat Commun; 2015 Apr; 6():6734. PubMed ID: 25828455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.
    Elangovan S; Pathania R; Ramachandran S; Ananth S; Padia RN; Lan L; Singh N; Martin PM; Hawthorn L; Prasad PD; Ganapathy V; Thangaraju M
    Cancer Res; 2014 Feb; 74(4):1166-78. PubMed ID: 24371223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells.
    Zimmerman MA; Singh N; Martin PM; Thangaraju M; Ganapathy V; Waller JL; Shi H; Robertson KD; Munn DH; Liu K
    Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(12):G1405-15. PubMed ID: 22517765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages.
    Feingold KR; Moser A; Shigenaga JK; Grunfeld C
    J Lipid Res; 2014 Dec; 55(12):2501-8. PubMed ID: 25320346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.
    Felizardo RJF; de Almeida DC; Pereira RL; Watanabe IKM; Doimo NTS; Ribeiro WR; Cenedeze MA; Hiyane MI; Amano MT; Braga TT; Ferreira CM; Parmigiani RB; Andrade-Oliveira V; Volpini RA; Vinolo MAR; Mariño E; Robert R; Mackay CR; Camara NOS
    FASEB J; 2019 Nov; 33(11):11894-11908. PubMed ID: 31366236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial metabolite butyrate modulates granzyme B in tolerogenic IL-10 producing Th1 cells to regulate intestinal inflammation.
    Yang W; Yu T; Liu X; Yao S; Khanipov K; Golovko G; Olivares-Villagómez D; Cong Y
    Gut Microbes; 2024; 16(1):2363020. PubMed ID: 38841892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR109a Regulates Phenotypic and Functional Alterations in Macrophages and the Progression of Type 1 Diabetes.
    Zhang Z; Li J; Zhang M; Li B; Pan X; Dong X; Pan LL; Sun J
    Mol Nutr Food Res; 2022 Dec; 66(23):e2200300. PubMed ID: 36208084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.
    Furusawa Y; Obata Y; Fukuda S; Endo TA; Nakato G; Takahashi D; Nakanishi Y; Uetake C; Kato K; Kato T; Takahashi M; Fukuda NN; Murakami S; Miyauchi E; Hino S; Atarashi K; Onawa S; Fujimura Y; Lockett T; Clarke JM; Topping DL; Tomita M; Hori S; Ohara O; Morita T; Koseki H; Kikuchi J; Honda K; Hase K; Ohno H
    Nature; 2013 Dec; 504(7480):446-50. PubMed ID: 24226770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFNγ Induces DNA Methylation-Silenced GPR109A Expression via pSTAT1/p300 and H3K18 Acetylation in Colon Cancer.
    Bardhan K; Paschall AV; Yang D; Chen MR; Simon PS; Bhutia YD; Martin PM; Thangaraju M; Browning DD; Ganapathy V; Heaton CM; Gu K; Lee JR; Liu K
    Cancer Immunol Res; 2015 Jul; 3(7):795-805. PubMed ID: 25735954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumour suppressor in colon that protects against colitis and colon cancer under low-fibre dietary conditions.
    Gurav A; Sivaprakasam S; Bhutia YD; Boettger T; Singh N; Ganapathy V
    Biochem J; 2015 Jul; 469(2):267-78. PubMed ID: 25984582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses.
    Wu S; Rhee KJ; Albesiano E; Rabizadeh S; Wu X; Yen HR; Huso DL; Brancati FL; Wick E; McAllister F; Housseau F; Pardoll DM; Sears CL
    Nat Med; 2009 Sep; 15(9):1016-22. PubMed ID: 19701202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypophagic response to heat stress is not mediated by GPR109A or peripheral β-OH butyrate.
    Hepler C; Foy CE; Higgins MR; Renquist BJ
    Am J Physiol Regul Integr Comp Physiol; 2016 May; 310(10):R992-8. PubMed ID: 26936786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases.
    Singh N; Thangaraju M; Prasad PD; Martin PM; Lambert NA; Boettger T; Offermanns S; Ganapathy V
    J Biol Chem; 2010 Sep; 285(36):27601-8. PubMed ID: 20601425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 100.